Rhesus Factor Controls Renal Function And Male Fertility, Université libre de Bruxelles Study 11/20/2008
More...
|
Pervasis Therapeutics Announces Promising Efficacy Results from Phase 1 and 2 Clinical Trials of Vascugel(R) in Dialysis Patients Needing Permanent AV Access, Data Builds on Compelling Safety Findings 11/19/2008
More...
|
Affymax, Inc. (AFFY) Completes Enrollment in Phase 3 Program for Hematide in Chronic Renal Failure with Completion of Enrollment in EMERALD 2, the Final of Four Phase 3 Clinical Trials of Hematide(TM) 11/17/2008
More...
|
Affymax, Inc. (AFFY) Completes Enrollment in EMERALD 1, the Third of Four Phase 3 Clinical Trials of Hematide(TM) to Treat Anemia in Chronic Renal Failure Patients 11/13/2008
More...
|
Affymax, Inc. (AFFY) Announces New Data Presented on the Long-Term Safety and Effectiveness of Hematide(TM) to Treat Anemia in Chronic Renal Failure Patients with Monthly Dosing 11/6/2008
More...
|
Affymax, Inc. (AFFY) Completes Enrollment in PEARL 2, the Second of Four Phase 3 Clinical Trials of Hematide to Treat Anemia in Chronic Renal Failure Patients 11/3/2008
More...
|
Affymax, Inc. (AFFY) Completes Enrollment in PEARL 1, the First of Four Phase 3 Clinical Trials of Hematide(TM) to Treat Anemia in Chronic Renal Failure Patients 7/9/2008
More...
|
Affymax, Inc. (AFFY) Initiates Clinical Trial of Hematide™ to Evaluate Correction of Anemia in Chronic Renal Failure Patients on Dialysis 6/30/2008
More...
|
Altus Pharmaceuticals Inc. (ALTU)'s ALTU-237 Achieves Favorable Saftey Profile In Phase 1 Trial 6/3/2008
More...
|
Combo Kidney-Pancreas Transplant Boosts Survival In Diabetics; Type 1 Patients Did Better Than Those Having Kidney Replacement Alone, University of Heidelberg Study 5/22/2008
More...
|
SGX Pharmaceuticals, Inc. (SGXP) Discontinued Development of SGX523; Announces First Quarter Financial Results 5/13/2008
More...
|
Unique Pattern of Gene Expression Can Indicate Acetaminophen Overdose 11/1/2007
More...
|
Device Offers New Treatment for Liver Failure 10/30/2007
More...
|
Affymax, Inc. (AFFY) Doses First Patient in the Phase 3 Clinical Program of Hematide(TM) to Treat Anemia in Chronic Renal Failure Patients 10/11/2007
More...
|
Keryx Biopharmaceuticals (KERX) Licenses Rights to Japan Tobacco; Torii Pharmaceutical Co. to Pay up to $100 Million 9/26/2007
More...
|
Ortho Biotech Products, L.P. Supports FDA Advisory Committees' Recommendations on Use of ESAs in Chronic Renal Failure Patients 9/12/2007
More...
|
Amgen (AMGN) Defends Anemia Drugs Before U.S. Panel 9/11/2007
More...
|
Renal Solutions Announces Collaborative Agreement with Innovative BioTherapies 8/27/2007
More...
|
Quark Pharmaceuticals Inc. (QURK) Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF) 8/2/2007
More...
|
Arbios Systems (ABOS) Reports Favorable Results From the SEPET(TM) Feasibility Clinical Trial 4/3/2007
More...
|
Sucampo Pharmaceuticals, Inc. Initiates Post-Marketing Studies of AMITIZA(R) in Subjects with Renal or Hepatic Impairment 3/13/2007
More...
|
FDA Approves New Dosing Recommendations For Wyeth (WYE)'s (Jobs) RAPAMUNE In High Immunologic Risk Renal Transplant Patients 2/2/2007
More...
|
La Jolla Pharmaceutical Company (LJPC) Announces Continued Enrollment Progress And Enhancements To International Phase 3 Riquent(R) Study 2/1/2007
More...
|
Genzyme Corporation (GENZ)'s Renagel In New Dialysis Study Published In Kidney International 1/8/2007
More...
|
Pervasis Therapeutics Announces Successful Initial Safety Results Of Phase I Trials Of Vascugel(TM) Cell-Based Gel To Repair Arteries 11/15/2006
More...
|
Guerbet (GBT) - Another Proof That There Is No Difference Between Low-Osmolarity Contrast Agents And Iso-Osmolar Agent For Prevention Of Contrast-Induced Nephropathy 10/27/2006
More...
|
ZymoGenetics, Inc. (ZGEN) Begins Phase 1/2 Clinical Trial With IL-21 And Nexavar In Patients With Renal Cell Cancer 10/17/2006
More...
|
Plexxikon Inc. And Servier Signed Cardiovascular Collaboration; Payments Totaling Over $100M 10/2/2006
More...
|
Antisoma PLC (ASM.L) Announces Positive Phase I Data On AS1411, Plans Phase II Trials In Renal And Blood Cancers 10/2/2006
More...
|
La Jolla Pharmaceutical Company (LJPC) Provides Update On Phase 3 International Riquent(R) Study 9/27/2006
More...
|
Pervasis Therapeutics' Vascugel(TM) Initiates U.S. Clinical Trials Following Successful Pervasis Therapeutics IND Review 9/27/2006
More...
|
Second Dramatic Response Seen With Antisoma PLC (ASM.L)'s AS1411 In Renal Cancer 9/8/2006
More...
|
Alternative Kidney Test Reveals Hidden Health Risks 8/15/2006
More...
|
Drinking Tea May Stave Off Bile Stones And Cancer 7/10/2006
More...
|
Neurochem, Inc. (NRMX) Release: Eprodisate (Fibrillex(TM)) Data Presented At The Meeting Of The European League Against Rheumatism (EULAR) 6/22/2006
More...
|
Successful Transplantation From Pig Embryos To Mice 6/20/2006
More...
|
Feds Warn San Francisco Kaiser Permanente 6/8/2006
More...
|
Fake Chinese Drug Kills Nine 5/22/2006
More...
|
Bogus Drugs Kill 4 In Southern China 5/17/2006
More...
|
NephroGenex Licenses Pyridorin(TM) For Diabetic Nephropathy And Acute Renal Failure 5/10/2006
More...
|
Bowel Cleansers Get FDA Warning 5/8/2006
More...
|
NxStage Medical, Inc. (NXTM) Achieves Milestone With 500 Patients On Therapy 5/1/2006
More...
|
New Research Demonstrates Bone-marrow Derived Stem Cells Can Reverse Genetic Kidney Disease 4/28/2006
More...
|
Ortho Biotech Products, L.P. Release: Data From Correction Of Hemoglobin And Outcomes In Renal Insufficiency (CHOIR) Study Presented At National Kidney Foundation Meeting 4/21/2006
More...
|
Exelixis, Inc. (EXEL) Intiates Phase II Clinical Program For XL784 3/27/2006
More...
|
Yale University Researchers Identify Gene Depth Protects Against Kidney Stones 3/13/2006
More...
|
Ginger May Prevent Diabetic Kidney Damage 3/10/2006
More...
|
Anabolic Steroid Use Increases Heart Attack Risk And Causes Liver Damage 2/17/2006
More...
|
Keryx Biopharmaceuticals (KERX) Announces Expansion Of Renal Franchise With The In-Licensing Of Zerenex(TM), A Novel Phosphate Binder 2/15/2006
More...
|
Scientists Find Genetic Pathway That Could Lead To Drugs For Kidney Disease 2/3/2006
More...
|
Boston Scientific Corporation (BSX) Announces Excellent Results In Study Of Patients With Renal Artery Disease 1/24/2006
More...
|
Scientists Spot Gene Behind Fatal Infant Kidney Disorder 1/13/2006
More...
|
Study Links Obesity To Kidney Failure 1/3/2006
More...
|
Kissei Pharmaceutical Co., Ltd. And JCR Pharmaceuticals Enter Into Joint Research Agreement For JR-013, Recombinant Human Erythropoietin-Based Renal Anemia Agent 12/27/2005
More...
|
Diazyme Laboratories Receives FDA 510(K) Approval For Enzymatic Total Bile Acids Assay Kit 12/22/2005
More...
|
Exelixis, Inc. (EXEL) Initiates Phase II Clinical Program For XL999 12/20/2005
More...
|
Unexpected Link Between Gene In Liver And Iron Overload 12/6/2005
More...
|
Coffee And Tea Can Reduce The Risk Of Chronic Liver Disease 12/2/2005
More...
|
Shire Pharmaceuticals Group plc (SHPGY) Release: New Formulation Of FOSRENOL(R) Approved To Reduce Phosphorus In End-Stage Renal Disease Patients 11/30/2005
More...
|
Shire Pharmaceuticals Group plc (SHPGY) Release: New Publication Demonstrates The Long-Term Efficacy, Safety And Tolerability Of FOSRENOL(R) 10/24/2005
More...
|
Myfortic Better For Kidney Patients 10/19/2005
More...
|
FDA, Eli Lilly Warn On Liver Damage With Cymbalta 10/18/2005
More...
|
Expert Review Of Molecular Diagnostics Features Signet Laboratories, Inc. Nephroscreen(TM) In Recent Publication 10/11/2005
More...
|
Scientists Learn To Predict Protein-Stabilizing Ability Of Small Molecules 10/7/2005
More...
|
RenaMed Biologics And Genzyme Corporation (GENZ) Announce Worldwide Collaboration To Advance Investigational Treatment For Acute Renal Failure 9/28/2005
More...
|
"Designer" Rats Yield Clues To Hypertension 9/23/2005
More...
|
Mayo Clinic Finds Kidney Disease Associated With "Benign" Prostate Obstruction 6/29/2005
More...
|
Gene Variant Linked To Chronic Kidney Disease 6/15/2005
More...
|
Chugai Pharmaceutical Co., Ltd. (Japan) To Establish New Business Unit To Boost Its Marketing Operations 6/13/2005
More...
|
Discovery May Prevent Life-Threatening Wasting Disease In Patients With Chronic Kidney Disease 6/10/2005
More...
|
La Jolla Pharmaceutical Company (LJPC) Provides Update On Riquent; Warns Of Financing Shortage 5/31/2005
More...
|
Nephros Inc. (NEP) Initiates Supplemental European Clinical Trials For OLpur MD190 5/26/2005
More...
|
Gene Yields Clues To Chronic Kidney Disease 5/6/2005
More...
|
Bone Care International Inc. (BCII) Announces Advancement Of LR-103 Into Human Patients With Stage 5 Chronic Kidney Disease 5/6/2005
More...
|
Mayo Clinic First To Use Pharmacogenomics To Treat Inherited Kidney Disorder Of Children 5/5/2005
More...
|
Protein Design Labs, Inc. (PDLI) And Orphan Therapeutics, LLC Report Fast Track Designation For Terlipressin In Type 1 Hepatorenal Syndrome 4/21/2005
More...
|
Neurochem, Inc. (NRMX) Says Fibrillex Failed To Meet Study Goal 4/18/2005
More...
|
Human Kidney Protein Found That Regulates Heart Contraction And Blood Pressure 4/8/2005
More...
|
Quick Kidney Failure Test "Found" 4/4/2005
More...
|
Mouse Model Reveals Potential Way To Reduce Cardiac Deaths In Kidney Patients 3/30/2005
More...
|
Protein Protects Kidneys From Damage Caused By Chronic Renal Disease And Injury 3/29/2005
More...
|
Amgen (AMGN) Releaes: Landmark Trial Will Evaluate The Impact Of Treating Anemia On Cardiovascular Outcomes In Patients With Chronic Kidney Disease And Type 2 Diabetes 3/29/2005
More...
|
Deficiency Of Growth Hormone And IGF-1 Reduces Cancer And Kidney Disease, But Creates Other Problems 3/24/2005
More...
|
Renin Alliance Of Actelion Ltd. (SW:ATLN) And Merck & Co., Inc. (MRK) Achieves Second Milestone; Actelion Receives USD 5 Million Following Selection Of First Compound To Enter Full Pre-Clinical Development 3/15/2005
More...
|
Gamida Cell Ltd. Names Dr. Yael Margolin As The Company's New President And CEO; StemEx Receives FDA Orphan Drug Designation 3/15/2005
More...
|
La Jolla Pharmaceutical Company (LJPC) Announces Outcome Of Recent FDA Discussions; Riquent(R) (abetimus sodium) Is Unlikely To Receive An Accelerated Approval 3/14/2005
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) To Hold Conference Call To Discuss 2004 Financial And Operating Results On Tuesday, March 15, At 10 AM EST 3/11/2005
More...
|
MethylGene Announces Year-End 2004 Results 3/9/2005
More...
|
Inotek Announces Special Protocol Assessment Agreement With The FDA For A Pivotal Trial For INO-1001 3/4/2005
More...
|
Quark Biotech, Inc. Receives Notice Of Allowance For U.S. Patent On p53 Inhibitor 3/3/2005
More...
|
Duke Researchers Uncover Genetic Link To Kidney Damage After Heart Surgery 3/1/2005
More...
|
GlaxoSmithKline (GSK) Release: Kidney Dysfunction In HIV Patients May Be Detected Earlier Using Estimated GFR Compared To Measures Of Serum Creatinine Only 2/28/2005
More...
|
New Clues To Protecting Diabetic Kidneys 2/24/2005
More...
|
Investigational Transplant Drug Effectively Preserves Kidneys While Avoiding Toxic Side Effects 2/23/2005
More...
|
Jefferson Scientists Uncover Potential Trigger Of Diabetic Kidney Disease 2/22/2005
More...
|
ParinGenix Inc. Gets FDA Approval Of IND For PGX-100 2/9/2005
More...
|
Spectrum Pharmaceuticals (SPPI) Licenses RenaZorb(TM) From Altair Nanotechnologies (ALTI) 1/31/2005
More...
|
Spire Corporation (SPIR) Receives National Science Foundation Grant To Develop Blood-Compatible Catheters 1/31/2005
More...
|
Test To Spot Early Liver Disease 12/28/2004
More...
|
Chromosome 16 Publication Fulfills DOE's Human Genome Commitment 12/23/2004
More...
|
Ciphergen Partnering With The EU Funded ADDNET Consortium To Discover And Develop Diagnostics Of Renal Disease 12/15/2004
More...
|
Medifacts International Announces Opening Of Pharmacokinetic/Dynamic Unit In Görlitz, Germany
12/2/2004
More...
|
FDA Issues Approvable Letter For Yamanouchi Pharma America, Inc.'s Investigational Hyponatremia Treatment Conivaptan Hydrochloride Injection 12/1/2004
More...
|
La Jolla Pharmaceutical Company (LJPC) Provides Update On Riquent Program 11/23/2004
More...
|
ESP Pharma, Inc. Announces FDA Grants Orphan Drug Status To I.V. Terlipressin, A Phase III Development Drug For The Treatment Of Life-Threatening Type 1 Hepato-Renal Syndrome 11/10/2004
More...
|
GenoMed, Inc. Finds Latest ACE Inhibitor Study ("PEACE") Also Fatally Flawed 11/10/2004
More...
|
Vivant Medical And Wake Forest University Baptist Medical Center Announce Completion Of An Ablate And Resect Study Of Renal Tumors 11/10/2004
More...
|
Tm Bioscience Corporation (CV:TMC) Announces New Collaboration With Genzyme Corporation (GENZ) 11/9/2004
More...
|
Cyclacel Group plc Release: Beneficial Effects Of Seliciclib (CYC202) Reported In Models Of Kidney Disease 11/8/2004
More...
|
Nabi Biopharmaceuticals (NABI) Files PhosLo(R) Common Technical Document In Europe 11/5/2004
More...
|
Renal Solutions To Present At The CIBC World Markets Fifteenth Annual Healthcare Conference 11/5/2004
More...
|
Diabetic Damage To Eyes, Heart, Nerves, Kidneys May Be Explained By Controversial Theory 11/3/2004
More...
|
Sanmina-SCI Corporation (SANM) And Renal Solutions Announce Strategic Manufacturing Agreement 11/3/2004
More...
|
Signet Laboratories, Inc. Announces Availability Of P504s IVD Monoclonal Antibody For Prostate Cancer Detection 11/2/2004
More...
|
Blood Pressure Drugs Protect Diabetics' Kidneys; One Drug Prevents Early Problems, The Other Halts Progression Of Disease 11/1/2004
More...
|
Yamanouchi Pharma America, Inc. Release: New Data From Two Studies Support Efficacy And Tolerability Of Vasopressin Receptor Antagonist Conivaptan Hydrochloride In Patients With Hyponatremia 11/1/2004
More...
|
Bone Care International Inc. (BCII) Release: Symposium On Role Of Vitamin D In Managing Chronic Kidney Disease Highlights Data From Hectorol(R) Study 11/1/2004
More...
|
AstraZeneca's Crestor May Harm Kidneys, Group Says 10/29/2004
More...
|
La Jolla Pharmaceutical Company (LJPC) Presents At American College of Rheumatology And American Society of Nephrology (ASN) Annual Meetings 10/29/2004
More...
|
Shire Pharmaceuticals Group PLC (SHPGY) Release: FOSRENOL(R) Maintains Bone Health Status Of End-Stage Renal Disease Patients 10/29/2004
More...
|
Genzyme Corporation (GENZ) Release: Investigators Announce First Results From RIND Study; Data Support Renagel Use In New Dialysis Patients 10/29/2004
More...
|
Shire Pharmaceuticals Group PLC (SHPGY) Release: FDA Approves New Therapy For Dialysis Patients With Hyperphosphatemia Medication Shows Long-Term Efficacy 10/28/2004
More...
|
Shire Pharmaceuticals Group PLC (SHPGY) Release: FDA Approves FOSRENOL(R) To Reduce Phosphorus Levels In End-Stage Renal Disease Patients 10/27/2004
More...
|
FDA Approval Of FOSRENOL Triggers U.S. $18 Million Payment To AnorMED (AOM.TO) 10/27/2004
More...
|
Dimercaptosuccinic Acid Does Not Lower Homocysteine In Dialysis Patients 10/14/2004
More...
|
LAB International (CC:LAB) Announces Positive Results From Phase I/II GHRH Analogue Trial 9/30/2004
More...
|
Trial Therapy May Fight Genetic Disorders 9/29/2004
More...
|
Astra's Exanta Requires Monthly Liver Tests 8/30/2004
More...
|
Baby Born With Heart Outside Body 7/21/2004
More...
|
Signet Laboratories, Inc. To Develop Predictive Diagnostics And Preventive Therapeutics For Treating Sepsis And Acute Renal Failure (S/ARF) 7/21/2004
More...
|
UK's Shire Pharmaceuticals Group PLC (SHPGY) Sees Delay In U.S. Kidney Drug Approval 7/20/2004
More...
|
Dragon Pharmaceuticals' (DRUG) Recombinant Erythropoietin (EPO) Product Receives Market Approval In Ecuador 7/16/2004
More...
|
Neurochem, Inc.'s (NRMX) Fibrillex Selected For New FDA Pilot 2 Program 7/7/2004
More...
|
Signet Laboratories, Inc. Releases NEPHROSCREEN(TM), The First RUO Diagnostic To Predict And Help Prevent Acute Renal Failure 6/29/2004
More...
|
Metabasis Therapeutics (MBRX) HepDirect(TM) Liver Targeting Prodrug Technology Described In The Journal Of The American Chemical Society 6/25/2004
More...
|
FDA Adds Warning To Serzone 6/24/2004
More...
|
Newly Grown Kidneys Can Sustain Life In Rats 6/22/2004
More...
|
FDA: Use Caution When Prescribing Crestor 6/10/2004
More...
|
Wyeth Pharmaceuticals (WYE) Release: Important New Study Findings For RAPAMUNE 6/10/2004
More...
|
ESP Pharma, Inc. And Orphan Therapeutics In Agreement To Develop And Commercialize I.V. Terlipressin For Treating Life-Threatening Type 1 Hepato-Renal Syndrome 6/8/2004
More...
|
Urine Protein Test: A Tipoff To Kidney Transplant Rejection 5/21/2004
More...
|
Can Caffeine Prevent Liver Damage? 5/20/2004
More...
|
AstraZeneca Cautions Doctors On High Dose Crestor 5/18/2004
More...
|
Shire Pharmaceuticals Group PLC (SHPGY) Release: First Approval For FOSRENOL(R) 3/24/2004
More...
|
Signet Laboratories, Inc. Announces Receipt Of "Notice of Allowance" In Europe For Patents Protecting Their Sepsis And Renal Failure Assay Technology 3/22/2004
More...
|
Group Sues FDA Over Drug Linked To Liver Damage 3/16/2004
More...
|
New Hypertension Drug Shows Promise In Renal Patients 3/9/2004
More...
|
Marshall Edwards, Inc. (NVGN) Commences Renal Cancer Human Trial Of Phenoxodiol In Combination Therapy 3/8/2004
More...
|
Drugs Cut Kidney Failure Risk In Lupus 3/4/2004
More...
|
Vasopressin Receptor Blocker Acts Against Polycystic Kidney Disease In Mice 3/1/2004
More...
|
Isotechnika Inc. (CT:ISA) Receives Notice Of Allowance For Third United States Patent Pertaining To ISA247 2/26/2004
More...
|
Isotechnika Inc. (CT:ISA) Release: FDA Agrees To Clinical Development Plans For ISA247 2/25/2004
More...
|
Nanobac Pharmaceuticals, Inc. Announces Confirming Results Of The Presence Of Nanobacteria In Renal Stones 2/23/2004
More...
|
FlowMedica, Inc. Receives 510(k) Clearance From FDA For Its Bifurcated Infusion System 2/20/2004
More...
|
Isotechnika Inc. (CT:ISA) - FDA Agrees To Manufacturing Plans For ISA247 2/19/2004
More...
|
What Hurts the Heart Also Hurts the Kidney; Study Finds Same Factors Increase Risk For Both Diseases 2/18/2004
More...
|
La Jolla Pharmaceutical Company's (LJPC) New Drug Application For Lupus Drug Candidate Riquent(R) Accepted For Review By FDA 2/17/2004
More...
|
Rockwell Medical Technologies Reports Grant Awarded For Proprietary Dialysate Iron Therapy Study 2/17/2004
More...
|
GenoMed, Inc. Appeals To Communities Of Color To Decrease Needless Deaths From Kidney Disease 2/17/2004
More...
|
Isotechnika Inc. (CT:ISA) Granted United States Patent For Cyclosporine Antibodies 2/9/2004
More...
|
Test May Warn Of Serious Pregnancy Complication 2/5/2004
More...
|
AnorMED (AOM.TO) Expands FOSRENOL(R) Licensing Agreement With Shire Pharmaceuticals Group PLC (SHPGY) 1/13/2004
More...
|
La Jolla Pharmaceutical Company (LJPC) Submits New Drug Application For Riquent(TM) 12/16/2003
More...
|
DaVita Inc. (DVA) Acquires Outpatient Kidney Dialysis Programs In Maryland And Georgia 12/16/2003
More...
|
Shire Pharmaceuticals Group PLC (SHPGY) Out-Licenses FOSRENOL(R) To Bayer In Japan 12/9/2003
More...
|
Datascope Corporation (DSCP) To Enter Dialysis Access Market With ProLumen(TM) 12/9/2003
More...
|
Cause Of Digestive Disorder Found 12/8/2003
More...
|
Painkillers "Cause Kidney Damage" 11/24/2003
More...
|
Diet Can Alter Risk Of Kidney Stones 11/18/2003
More...
|
Amgen's (AMGN) Cinacalcet HCl Phase 3 Results Demonstrate Improvement In The Management Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 11/17/2003
More...
|
Monthly Dosing Can Control Anemia In Kidney Disease 11/17/2003
More...
|
La Jolla Pharmaceutical Company (LJPC) Presents Results Linking Antibodies To dsDNA With Renal Flares 11/17/2003
More...
|
Advanced Magnetics' (AVM) Ferumoxytol Shows Potential Advantages In Treatment Of Anemia In Chronic Kidney Disease 11/17/2003
More...
|
BioStratum Presents Positive Phase 2 Clinical Study Results At The American Society Of Nephrology's 36th Annual Meeting And Scientific Exposition 11/17/2003
More...
|
Nabi Biopharmaceuticals (NABI) Release: Data Presented At The 36th Annual American Society Of Nephrology Meeting Continues To Support PhosLo(R) For First-Line Treatment For Hyperphosphatemia In End-Stage Renal Disease Patients 11/17/2003
More...
|
Amgen's (AMGN) Aranesp(R) Administered Once Monthly Maintains Hemoglobin Levels In Patients With Chronic Kidney Disease 11/17/2003
More...
|
GlaxoSmithKline's (GSK) Study Results Demonstrate Argatroban Was Well Tolerated In End-Stage Renal Disease Patients Undergoing Hemodialysis 11/17/2003
More...
|
Rikshospitalet University Hospital Release: ALERT Study Confirms Early Treatment With Fluvastatin Significantly Reduces Risk Of Coronary Heart Disease In Kidney Transplant Patients 11/17/2003
More...
|
Nabi Biopharmaceuticals (NABI) Release: Data Presented At The 36th Annual American Society Of Nephrology Meeting Continues To Support PhosLo(R) For First-Line Treatment For Hyperphosphatemia In End-Stage Renal Disease Patients 11/14/2003
More...
|
Abbott Laboratories (ABT) Launches Global Research Program To Study Effects Of D-Receptor Activation In Patients With Chronic Kidney Disease 11/14/2003
More...
|
Baxter Healthcare Corporation (BAX) Announces The Launch Of First-Of-Its-Kind Chronic Kidney Disease Research Program To Develop A New Model Of Renal Disease Care 11/14/2003
More...
|
Susceptibility Genes May Explain High Rate Of Diabetic Kidney Failure In Blacks 11/14/2003
More...
|
Hypertension Harder To Control In Women 11/13/2003
More...
|
Baxter Healthcare Corporation (BAX) Release: New Data Published In Leading Nephrology Journal Suggest At-Home Dialysis An Effective Option For More Patients With Advanced Kidney Disease 11/13/2003
More...
|
aaiPharma Inc. (AAII) Announces Exclusive License Agreement With Salix Pharmaceuticals, Ltd. (SLXP) For Azasan(R) 11/4/2003
More...
|